Your browser doesn't support javascript.
loading
Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase.
Powell, Noel A; Hoffman, Jennifer K; Ciske, Fred L; Kohrt, Jeffrey T; Baxi, Sangita M; Peng, Yun-Wen; Zhong, Min; Catana, Cornel; Ohren, Jeff; Perrin, Lisa A; Edmunds, Jeremy J.
Affiliation
  • Powell NA; Pfizer Global Research & Development, Michigan Laboratories, Ann Arbor, MI 48105, USA. napowell@comcast.net
Bioorg Med Chem Lett ; 23(4): 1051-5, 2013 Feb 15.
Article in En | MEDLINE | ID: mdl-23312943
ABSTRACT
Optimization of the ADME properties of a series of 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase resulted in the identification of highly selective compounds with properties suitable for use as in vitro and in vivo tools to probe the effects of Sky inhibition.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Receptor Protein-Tyrosine Kinases / Protein Kinase Inhibitors Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2013 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Receptor Protein-Tyrosine Kinases / Protein Kinase Inhibitors Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2013 Document type: Article Affiliation country: United States